Systemic chemotherapy in metastatic colorectal adenocarcinomas
Bécouarn, Y.; Brunet, R.; Ravaud, A.; Bussières, E.; Lagarde, P.
Gastroenterologie Clinique et Biologique 16(2): 166-176
1992
ISSN/ISBN: 0399-8320 PMID: 1568545 Document Number: 398340
Document emailed within 1 workday
Related Documents
Ide, Y.; Mikami, K.; Murata, K. 2009: Intermittent hepatic arterial infusion with systemic chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2172-2174Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Tanaka, K.; Kumamoto, T.; Nojiri, K.; Mori, R.; Matsuyama, R.; Takeda, K.; Ota, M.; Akiyama, H.; Ichikawa, Y.; Endo, I. 2010: Prehepatectomy chemotherapy using hepatic artery infusion plus systemic chemotherapy for liver metastases from colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2267-2270
Lin, C.-P.; Chi, P. 2009: Clinical study of postoperative intraperitoneal chemotherapy combined with systemic chemotherapy for serosa-involved colorectal cancer Zhonghua Wei Chang Wai Ke Za Zhi 12(3): 257-260
Kamnerdsupaphon, P.; Lorvidhaya, V.; Chitapanarux, I.; Tonusin, A.; Sukthomya, V. 2007: FOLFIRI chemotherapy for metastatic colorectal cancer patients Journal of the Medical Association of Thailand 90(10): 2121-2127
Muro, K. 2013: Team medicine in chemotherapy for metastatic colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 435-439
Mc Clay, E.F.; Mastrangelo, M.J. 1988: Systemic chemotherapy for metastatic melanoma Seminars in Oncology 15(6): 569-577
Conroy, T.; Marchal, F.; Briançon, S. 2000: Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer New England Journal of Medicine 342(20): 1525; Author Reply 1526-1527
Sasaki, K.; Takasaka, H.; Nishikawa, N.; Yoshikawa, T.; Hirata, K. 2003: Home chemotherapy and outpatient treatment for metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 7): 333-337
Sulkes, A.; Uziely, B.; Isacson, R.; Brufman, G.; Biran, S. 1988: Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas Israel Journal of Medical Sciences 24(9-10): 604-610
Iwasa, S.; Shimada, Y. 2011: Treatment strategy of chemotherapy for unresectable metastatic or recurrent colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 427-432
Takiuchi, H. 2011: Efficacy of monoclonal antibodies in combination with chemotherapy in metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 459-463
Koukourakis, G.; Kouloulias, V.; Zacharias, G.; Koukourakis, M. 2010: Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy Journal of Buon: Official Journal of the Balkan Union of Oncology 15(4): 652-659
Boussen, H.; Kallel, N.; Khomsi, F.; Jerbi, G.; Dhouib, R.; Ben Safta, Z.; Ben Abdesselem, M.; el May, M.; Gammoudi, A.; Benna, F.; Hamza, H.; Dziri, C.; Najah, N.; Zaouche, A.; Rahal, K.; Ben Ayed, F. 1999: Adjuvant chemotherapy after curative surgery for non-metastatic colorectal carcinomas (2-year results of 52 cases) La Tunisie Medicale 77(2): 61-67
Sun, K.; Wu, C.-t.; Lei, S.-t.; Huang, X.-c. 2010: Effects of FOLFOX4 neoadjuvant chemotherapy on the non-tumoral liver in patients with metastatic colorectal carcinoma Zhonghua Wei Chang Wai Ke Za Zhi 13(5): 350-353
Zhang, T.; Su, D.; Li, J.; Wang, Y.; Han, C.; Jiao, S.; Bai, L. 2015: Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma Zhonghua Wei Chang Wai Ke Za Zhi 18(6): 584-588
Li, J.; Xu, J-Ming.; Li, J.; Zhang, X-Dong.; Bai, Y.; Chu, Y-Ping.; Wang, Y-Hua.; Liu, D-Qi.; Jin, M-Lin.; Shen, L. 2008: Irinotecan plus fuorouracil/leucovorin (FOLFIRI) as a second line chemotherapy for refractory or metastatic colorectal cancer Zhonghua Zhong Liu Za Zhi 30(3): 225-227
Yamaguchi, Y.; Minami, K.; Kawabuchi, Y.; Emi, M. 2006: A phase I trial of CPT-11 in combination with 5-fluorouracil plus leucovorin chemotherapy for patients with metastatic colorectal cancer Hepato-Gastroenterology 53(68): 201-205
Berglund, A.; Edler, D.; Molin, D.; Nordlinder, H.; Graf, W.; Glimelius, B. 2002: Thymidylate synthase and p53 expression in primary tumor do not predict chemotherapy outcome in metastatic colorectal carcinoma Anticancer Research 22(6b): 3653-3659
Pajkos, G.; Szentpétery, L.; Kristó, K.; Izsó, J. 1998: Combined therapy of metastatic liver neoplasms: intrahepatic chemoembolization and systemic chemotherapy Orvosi Hetilap 139(17): 1013-1017